arrow
H

Hiroki Kiyohara

keio university school of medicine
H指数:25
被引数:2,098

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness and safety of tacrolimus versus infliximab as rescue therapy for intravenous corticosteroid-refractory acute severe ulcerative colitis: a multicenter cohort study

他克莫司与英夫利西单抗作为静脉糖皮质激素难治性急性重度溃疡性结肠炎救援治疗的有效性和安全性:一项多中心队列研究

2026-09-210
PRE
Diagnostic Performance and Reproducibility of Chromoendoscopic Classification (FOCUS Classification: Flat-Type Dysplasia Optical Assessment by Chromoendoscopy in Ulcerative ColitiS) for Flat-Type Dysplasia in Ulcerative Colitis–Associated Neoplasia

染色内镜分类(FOCUS分类:溃疡性结肠炎中染色内镜对平坦型异型增生的光学评估)对溃疡性结肠炎相关肿瘤的诊断性能和可重复性

2026-09-090
OAAI
Characterization of Computed Tomography Colonography Findings of Ulcerative Colitis-Associated Neoplasia

溃疡性结肠炎相关肿瘤的计算机断层结肠成像表现特征

2025-12-010
OAAI
Leucine-rich alpha-2 glycoprotein in combination with C-reactive protein for predicting endoscopic activity in Crohn's disease: a single-centre, cross-sectional study

富含亮氨酸的 α-2糖蛋白联合C反应蛋白预测克罗恩病的内镜活动: 一项单中心横断面研究

2025-01-170
OAAI
Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study
2024-04-080
OAAI
Clinical outcomes of patients with remitting ulcerative colitis after discontinuation of indigo naturalis

停用青黛后缓解型溃疡性结肠炎患者的临床结局

2024-03-092
OAAI
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study

新型冠状病毒肺炎胃肠道症状与疾病严重程度: 一项基于日本注册登记的回顾性队列研究

2024-01-255
PRE
Immunomodulators after the discontinuation of anti-tumor necrosis factor-alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study
2023-10-121
OA
Risk of venous thromboembolism with a central venous catheter in hospitalized Japanese patients with inflammatory bowel disease: a propensity score-matched cohort study

日本炎症性肠病住院患者使用中心静脉导管进行静脉血栓栓塞的风险: 倾向评分匹配队列研究

2023-07-312
OAAI